MHRA: Adverse drug reactions: Update on Anonymised Single Patient Reports (ASPRs): July 2010

The MHRA has implemented a series of changes to the logic which defines which marketing authorisation holders (MAHs) receive ASPRs/Individual Case Safety Reports (ICSRs). It is expected that these changes will result in a reduction in the number of ASPRs/ICSRs that MAHs receive.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny